Tag - pharmaceuticals

 
 

PHARMACEUTICALS

JAPAN / Science & Health
Jun 24, 2020
Wanted: More COVID-19 patients in Japan ... for clinical trials
Japan has become a victim of its own success as slowing new infections have led to a shortage of patients to enroll in trials for treatments and vaccines.
Japan Times
BUSINESS / Companies
Jun 23, 2020
Gilead targets remdesivir supply for 2 million COVID-19 patients by year-end
The company also said it hoped to start trials in August of an easier-to-use inhaled version of the medicine, which is currently administered only intravenously.
BUSINESS / Companies
Jun 22, 2020
Japan drugmaker to tie up with universities to develop new test method for coronavirus
Japanese pharmaceutical company Shionogi & Co. said Monday that it will collaborate with universities in the country to put into practical use a new testing method for the novel coronavirus.
Japan Times
BUSINESS / Markets
Jun 8, 2020
Chugai stock surges 60% to rival Sony's value on hopes for virus treatment
Chugai Pharmaceutical is now Japan's biggest drug company by market value after overtaking Daiichi Sankyo and Takeda Pharmaceutical.
Japan Times
WORLD / Science & Health
Jun 2, 2020
Scientists hunt pandemic hot spots in race to test vaccines
The first wave of the COVID-19 pandemic may be waning. For vaccine developers, that could be a problem.
Japan Times
WORLD / Science & Health
Jun 1, 2020
After fast-tracking Japanese COVID-19 drug, Russia to roll out 'game changer' next week
Russia will start administering its first approved antiviral drug to treat coronavirus patients next week, its state financial backer told Reuters, a move it described as "a game changer" that should speed a return to normal economic life.
Japan Times
BUSINESS / Markets
May 26, 2020
Japan’s AnGes continues surge as coronavirus vaccine candidate moves closer to human trials
The progress of its drug development has led to wild swings in the stock, with shares falling more than 50 percent in two trading sessions earlier this month.
Japan Times
WORLD / Science & Health
May 23, 2020
Gilead’s remdesivir mainly helped healthier COVID-19 patients
Gilead Sciences Inc.’s remdesivir, the first medicine cleared for the treatment of COVID-19, mainly benefited healthier patients who weren’t dependent on ventilators or heart-lung bypass machines, according to published results of the study used to get the medicine on the market.
Japan Times
BUSINESS
May 21, 2020
No pause in coronavirus trial for Avigan, Japan's lead researcher says
The lead researcher in the coronavirus trial for flu drug Avigan says it’s too early to make a call on whether it works and shrugged off negative reports about the interim results, saying patients are still being enrolled.
Japan Times
COMMENTARY / World
May 19, 2020
Vaccine developers need to take their time
Positive study results have arrived quickly, but the next steps will be slower.
Japan Times
WORLD
May 19, 2020
Trump says he’s taking anti-malaria drug that led to FDA warning
Trump is a self-admitted germophobe, telling reporters he was wary of shaking hands even before the coronavirus pandemic.

Longform

Professional cleaner Hirofumi Sakurai takes a moment to appreciate some photographs in a Gotanda apartment whose occupant died alone.
The last cleanup: Life and death in a lonely Japan